Countrywide Variables Associated With the Reduction of Fetuses With Down Syndrome

In this study, we sought to analyze the associations of global macroeconomic policy decisions on live births with Down syndrome (DS). As countries made prenatal screening more available and financially covered by their governments, we modeled the impact on the "reduction percentage" for DS-that is, the percentage of fetuses with DS that were not born as a consequence of selective terminations. The log-odds of the reduction in live births of children with DS (due to selective abortion) were estimated using maternal age-based prevalence models and actual birth data. These log-odds were then predicted using independent variables, including the availability and reimbursement of prenatal screening, maternal age, Gross National Income per capita, and country-specific effects. Data were analyzed using least squares regression with robust standard errors and model validation. When there is a full change from "no availability of screening" to "serum screening available and reimbursed," we observed a large effect on the reduction percentage (OR = 3.24, p = 0.0001). If a country, whose baseline reduction percentage was 5%, 25%, or 50%, were to make this policy switch, then the reduction would be expected to increase to about 15%, 52%, and 76%, respectively, when all other variables are held constant. Increases in maternal age and Gross National Income also were associated with increased reduction percentages. If a country were to expand the availability or reimbursement of prenatal screening for DS, while all other factors are constant, that country should also expect to have fewer live births with DS as a consequence.

Authors

Institutions

Publication Details

Journal
American Journal of Medical Genetics Part A
Published
2025-08-21
DOI
https://doi.org/10.1002/ajmg.a.64228
Primary Topic
Prenatal Screening and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Countrywide Variables Associated With the Reduction of Fetuses With Down Syndrome

F. Buckley, Gert de Graaf, Brian G. Skotko, Petrus H. F. M. van Casteren
American Journal of Medical Genetics Part A
Prenatal Screening and Diagnostics
article

Countrywide Variables Associated With the Reduction of Fetuses With Down Syndrome

F. Buckley, Gert de Graaf, Brian G. Skotko, Petrus H. F. M. van Casteren
article en

Abstract

In this study, we sought to analyze the associations of global macroeconomic policy decisions on live births with Down syndrome (DS). As countries made prenatal screening more available and financially covered by their governments, we modeled the impact on the "reduction percentage" for DS-that is, the percentage of fetuses with DS that were not born as a consequence of selective terminations. The log-odds of the reduction in live births of children with DS (due to selective abortion) were estimated using maternal age-based prevalence models and actual birth data. These log-odds were then predicted using independent variables, including the availability and reimbursement of prenatal screening, maternal age, Gross National Income per capita, and country-specific effects. Data were analyzed using least squares regression with robust standard errors and model validation. When there is a full change from "no availability of screening" to "serum screening available and reimbursed," we observed a large effect on the reduction percentage (OR = 3.24, p = 0.0001). If a country, whose baseline reduction percentage was 5%, 25%, or 50%, were to make this policy switch, then the reduction would be expected to increase to about 15%, 52%, and 76%, respectively, when all other variables are held constant. Increases in maternal age and Gross National Income also were associated with increased reduction percentages. If a country were to expand the availability or reimbursement of prenatal screening for DS, while all other factors are constant, that country should also expect to have fewer live births with DS as a consequence.

American Journal of Medical Genetics Part AVol. 200(1)
Harvard University (US), Massachusetts General Hospital (US), Rome Foundation (US), Down's Syndrome Association (GB), Hersenstichting (NL), Amsterdam University of Applied Sciences (NL), University of Amsterdam (NL), University of Cumbria (GB)
Openalex Percentile: Top 69%
Prenatal Screening and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.